Recurrent implantation failure is more frequently seen in female patients with poor prognosis
- PMID: 25493162
- PMCID: PMC4258244
Recurrent implantation failure is more frequently seen in female patients with poor prognosis
Abstract
Background: This study evaluated the characteristics and results of patients who suffer from recurrent implantation failure (RIF).
Materials and methods: In this cross sectional study, a total of 2183 cases who were evaluated retrospectively at the Istanbul University Cerrahpasa Medical Faculty, Department of Obstetrics and Gyneacology, IVF unit between 2000-2007. According to the data gathered, we included 1822 cases in this study. We compared 185 patients with RIF to 1637 women without RIF.
Results: Pregnancy was achieved by 589 couples out of 1822 (32%). The implantation rate was 10%, which declined to 5.8% after the fourth attempt. In the RIF group, patients' mean age was higher and there were more overweight women, the duration of fertility was longer, day 3 follicle stimulation hormone (FSH) levels and the total gonadotropin dose administered were higher, mean level of Estradiol (E2) on the human chorionic gonadotropin (hCG) day was lower, and the mean level of progesterone on the hCG day was elevated compared to the non-RIF group. Although the comparison of MII oocyte number was not significant, the mean number of fertilized oocytes was found to be significant in favor of the non-RIF group. The endometrial thicknesses were found to be similar for both groups. Comparison of sperm motility and morphology were statistically significant in favor of the RIF group.
Conclusion: In our study, we have found that the group with RIF were comprised of patients with poor prognosis who were older, overweight, had a longer infertility duration, a higher FSH level, and needed more gonadotropin doses in controlled ovarian hyperstimulation (COH). Sperm motility and morphology were better in the RIF group compared to the non-RIF group, and multiple pregnancy rates were lower in RIF patients.
Keywords: Implantation; In Vitro Fertilization; Recurrent Implantation Failure.
Similar articles
-
[Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].Zhonghua Fu Chan Ke Za Zhi. 2013 Nov;48(11):838-42. Zhonghua Fu Chan Ke Za Zhi. 2013. PMID: 24444561 Chinese.
-
The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.Clin Endocrinol (Oxf). 2018 Jan;88(1):77-87. doi: 10.1111/cen.13481. Epub 2017 Oct 16. Clin Endocrinol (Oxf). 2018. PMID: 28960429
-
[Smoothing Gan Reinforcing Shen Method Adjuvantly Treated Poor Response of Diminished Ovari- an Reserve Patients in in vitro Fertilization and Embryo Transfer: a Clinical Study].Zhongguo Zhong Xi Yi Jie He Za Zhi. 2015 Oct;35(10):1170-4. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2015. PMID: 26677665 Clinical Trial. Chinese.
-
Management of women with PCOS using myo-inositol and folic acid. New clinical data and review of the literature.Horm Mol Biol Clin Investig. 2018 Mar 2;34(2):/j/hmbci.2018.34.issue-2/hmbci-2017-0067/hmbci-2017-0067.xml. doi: 10.1515/hmbci-2017-0067. Horm Mol Biol Clin Investig. 2018. PMID: 29498933 Review.
-
The prevention of ovarian hyperstimulation syndrome.J Obstet Gynaecol Can. 2014 Nov;36(11):1024-1033. doi: 10.1016/S1701-2163(15)30417-5. J Obstet Gynaecol Can. 2014. PMID: 25574681 Review. English, French.
Cited by
-
Homocysteine serum levels correlate with the number of failed IVF cycles even when within normal range.Arch Gynecol Obstet. 2023 Jun;307(6):1975-1982. doi: 10.1007/s00404-023-06972-3. Epub 2023 Apr 10. Arch Gynecol Obstet. 2023. PMID: 37037915
-
Review of Endometrial Receptivity Array: A Personalized Approach to Embryo Transfer and Its Clinical Applications.J Pers Med. 2023 Apr 27;13(5):749. doi: 10.3390/jpm13050749. J Pers Med. 2023. PMID: 37240919 Free PMC article. Review.
-
ESHRE good practice recommendations on recurrent implantation failure.Hum Reprod Open. 2023 Jun 15;2023(3):hoad023. doi: 10.1093/hropen/hoad023. eCollection 2023. Hum Reprod Open. 2023. PMID: 37332387 Free PMC article.
-
Gonadotropin-releasing hormone agonist downregulation combined with hormone replacement therapy improves the reproductive outcome in frozen-thawed embryo transfer cycles for patients of advanced reproductive age with idiopathic recurrent implantation failure.Reprod Biol Endocrinol. 2022 Feb 3;20(1):26. doi: 10.1186/s12958-022-00897-3. Reprod Biol Endocrinol. 2022. PMID: 35115007 Free PMC article.
References
-
- El-Toukhy T, Taranissi M. Towards better quality research in recurrent implantation failure: standardizing its definition is the first step. Reprod Biomed Online. 2006;12(3):383–385. - PubMed
-
- Margalioth EJ, Ben-Chetrit A, Gal M, Eldar-Geva T. Investigation and treatment of repeated implantation failure following IVF-ET. Hum Reprod. 2006;21(12):3036–3043. - PubMed
-
- Tan SL, Child TJ, Cheung AP, Fluker MR, Yuzpe A, Casper R, et al. A randomized, double-blind, multicenter study comparing a starting dose of 100 IU or 200 IU of recombinant follicle stimulating hormone (Puregon) in women undergoing controlled ovarian hyperstimulation for IVF treatment. J Assist Reprod Genet. 2005;22(2):81–88. - PMC - PubMed
-
- Lukassen HG, Braat DD, Wetzels AM, Zielhuis GA, Adang EM, Scheenjes E, et al. Two cycles with single embryo transfer versus one cycle with double embryo transfer: a randomized controlled trial. Hum Reprod. 2005;20(3):702–708. - PubMed
-
- Martikainen H, Tiitinen A, Tomas C, Tapanainen J, Orava M, Tuomivaara L, et al. One versus two embryo transfer after IVF and ICSI: a randomized study. Hum Reprod. 2001;16(9):1900–1903. - PubMed
LinkOut - more resources
Full Text Sources